BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19091401)

  • 1. The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells.
    Tran KK; Shen H
    Biomaterials; 2009 Mar; 30(7):1356-62. PubMed ID: 19091401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.
    Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X
    J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.
    Blander JM
    Immunol Rev; 2016 Jul; 272(1):65-79. PubMed ID: 27319343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab22a controls MHC-I intracellular trafficking and antigen cross-presentation by dendritic cells.
    Cebrian I; Croce C; Guerrero NA; Blanchard N; Mayorga LS
    EMBO Rep; 2016 Dec; 17(12):1753-1765. PubMed ID: 27861124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autophagy in MHC class I-restricted antigen presentation.
    Van Kaer L; Parekh VV; Postoak JL; Wu L
    Mol Immunol; 2019 Sep; 113():2-5. PubMed ID: 29126597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
    Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
    Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells.
    Kim SH; Visser A; Cruijsen C; van der Velden AW; Boes M
    Infect Immun; 2008 Nov; 76(11):5373-80. PubMed ID: 18779337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing.
    Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M
    Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioorthogonal deprotection on the dendritic cell surface for chemical control of antigen cross-presentation.
    Pawlak JB; Gential GP; Ruckwardt TJ; Bremmers JS; Meeuwenoord NJ; Ossendorp FA; Overkleeft HS; Filippov DV; van Kasteren SI
    Angew Chem Int Ed Engl; 2015 May; 54(19):5628-31. PubMed ID: 25784151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.
    Cruz FM; Colbert JD; Merino E; Kriegsman BA; Rock KL
    Annu Rev Immunol; 2017 Apr; 35():149-176. PubMed ID: 28125356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-presentation by dendritic cells.
    Joffre OP; Segura E; Savina A; Amigorena S
    Nat Rev Immunol; 2012 Jul; 12(8):557-69. PubMed ID: 22790179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
    Segura E; Villadangos JA
    Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.
    Blander JM
    Semin Immunol; 2023 Mar; 66():101713. PubMed ID: 36706521
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Del Balzo D; Capmany A; Cebrian I; Damiani MT
    Front Immunol; 2021; 12():662096. PubMed ID: 33936099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells.
    Bougnères L; Helft J; Tiwari S; Vargas P; Chang BH; Chan L; Campisi L; Lauvau G; Hugues S; Kumar P; Kamphorst AO; Dumenil AM; Nussenzweig M; MacMicking JD; Amigorena S; Guermonprez P
    Immunity; 2009 Aug; 31(2):232-44. PubMed ID: 19699172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.